Tevogen highlights COVID-19 treatment data for immunocompromised patients
Go back to Tevogen highlights COVID-19 treatment data for immunocompromised patients| (NASDAQ: TVGN) | Delayed: 5.59 +0.02 (0.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.57 | 52 Week High | $ | |||
| Open | $5.50 | 52 Week Low | $ | |||
| Day High | $5.60 | P/E | N/A | |||
| Day Low | $4.74 | EPS | $ | |||
| Volume | 22,640 | |||||
| (NASDAQ: TVGNW) | Delayed: 0.05 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.05 | 52 Week High | $ | |||
| Open | $0.05 | 52 Week Low | $ | |||
| Day High | $0.05 | P/E | N/A | |||
| Day Low | $0.05 | EPS | $ | |||
| Volume | 7,791 | |||||

